Endogenous Nitric Oxide Synthase Inhibitors, Arterial Hemodynamics, and Subclinical Vascular Disease
- 1 December 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 52 (6), 1051-1059
- https://doi.org/10.1161/hypertensionaha.108.120352
Abstract
Endogenous NO synthase inhibitors (end-NOSIs) have been associated with cardiovascular risk factors and atherosclerosis. In addition, end-NOSIs may directly cause hypertension through hemodynamic effects. We aimed to examine the association between end-NOSI asymmetrical dimethylarginine (ADMA) and N-guanidino-monomethyl-arginine (NMMA), subclinical atherosclerosis, and arterial hemodynamics. We studied 922 adults participating in a population-based study (PREVENCION Study) and examined the correlation between end-NOSI/l-arginine and arterial hemodynamics, carotid-femoral pulse wave velocity, and carotid intima-media thickness using linear regression. ADMA, NMMA, and l-arginine were found to be differentially associated with various classic cardiovascular risk factors. ADMA and NMMA (but not l-arginine) were significant predictors of carotid intima-media thickness, even after adjustment for cardiovascular risk factors, C-reactive protein, and renal function. In contrast, ADMA and NMMA did not predict carot...Keywords
This publication has 37 references indexed in Scilit:
- Serum Asymmetric Dimethylarginine Negatively Correlates with Intima-Media Thickness in Early-Onset AtherosclerosisCerebrovascular Diseases, 2007
- Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study)Clinical Chemistry, 2007
- Association of Homocysteine and Asymmetric Dimethylarginine With Atherosclerosis and Cardiovascular Events in Maintenance Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2006
- Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunctionBiochemical and Biophysical Research Communications, 2006
- Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) studyAmerican Heart Journal, 2006
- ADMA Increases Arterial Stiffness and Decreases Cerebral Blood Flow in HumansStroke, 2006
- Design of PREVENCION: A population-based study of cardiovascular disease in PeruInternational Journal of Cardiology, 2005
- Diminished L-arginine bioavailability in hypertensionClinical Science, 2004
- Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine DimethylaminohydrolaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996